Clinical Trial

Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

Study acronym: MUCOthèque
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the relevance of Porphyromonas as a biomarker predicting the risk of P. aeruginosa primocolonization in children form 0 to 18 years old with cystic fibrosis.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-10-22; most recent amendment 2024-04-22.
Status change: Not Yet Recruiting → Recruiting 2022-03-23
Trial Details
NCT Number NCT04137133
Lead Sponsor University Hospital, Brest
Conditions Cystic Fibrosis
Enrollment 20 participants
Start Date 2022-03-21
Primary Completion 2030-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2024-04-23